With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
The Scientist
Most Recent
Ascribing benefits to the experience of devastating illness or trauma is fraught with hidden dangers.
New types of biological filaments are turning up in yeast, fly, bacterial cells and in rat neurons, and they may yield clues to how the cytoskeleton evolved from metabolically active enzymes.
A guide to free software for constructing and assessing species relationships
To ensure high-quality clinical trials of a malaria vaccine, organizers in rural Africa must first upgrade electrical and research infrastructures.
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
A transcription factor can make adult stem cells behave like fetal stem cells.
An antibody that binds 16 different flu viruses offers hope for the long-sought universal vaccine.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
